Taiyen Biotech reports Sep revenue NT$273.0 million
Taiyen Biotech Co. Ltd. reported Sep revenue of NT$273,039,000 versus NT$265,400,000 in 2025. Jan–Sep revenue was NT$2,383,558,000 versus NT$2,491,208,000 in 2025.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.